Kwaliteitsstandaard atypische parkinsonismen

Pagina 246 - McKeith IG, Dickson DW, Lowe J, Emre M, O'Brien JT, Feldman H,; Consortium on DLB . Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology. 2005;65(12):1863-72. - Meissner WG, Foubert-Samier A, Dupouy S, Debs R, Gerdelat-Mas A, Cochen De Cock V, et al. Validation of the French version of the MSA health-related quality of life scale (MSA-QoL). Rev Neurol 2012;168:809-14. - Meissner WG, Foubert-Samier A, Dupouy S, Gerdelat-Mas A, Debs R, Marquant F, et al. Assessment of quality of life with the multiple system atrophy health-related quality of life scale. Mov Disord 2012;27(12):1574-7. - Miyasaki, J. Treatment of Advanced Parkinson Disease and Related Disorders. review; Continuum (Minneap Minn) 2016;22(4):1104–1116. - Moretti, D. Are there treatments for atypical parkinsonism? An update on actual options. Rev. Neurosci. 2015; 26(5): 547–553. DOI 10.1515/revneuro-2015-0008 - Muhiddin, K., Hardie, R., Pearce, V., Kirby, B. Corticobasal degeneration: a report of three cases. Journal of the Royal Society of Medicine Volume 87 June 1994 359 - Palma JA, Norcliffe-Kaufmann L, Kaufmann H. Diagnosis of multiple system atrophy . Auton Neurosci. 2 018 May;211:15-25. - Parma, V., Zanatto, D., Straulino, E., Scaravili, T. et al. Kinematics of the reach-to-grasp movement in vascular parkinsonism: a comparison with idiopathic Parkinson’s disease patiënts. Frontiers in neurology May 2014 | Volume 5 | Article 75 - Perez-Lloret S, Flabeau O, Fernagut P, Pavy-Le Traon A, et al. Current concepts in the treatment of multiple system atrophy. Mov Dis 2014. - Poewe, W., Mahlknecht, P., Krismer, F. Therapeutic Advances in Multiple System Atrophy and Progressive Supranuclear Palsy. Movement Disorders, Vol. 00, No. 00, 2015. - Possin, K. Visual Spatial Cognition in Neurodegenerative Disease. Neurocase. 2010 December ; 16(6): 466– 487. doi:10.1080/13554791003730600. - Rehman H. Progressive supranuclear palsy. Postgrad Med J 2000;76:333–336. - Rehman H. Multiple system atrophy. Postgrad Med J 2001;77:379–382. - Rijk, de, M., Breteler, M., Graveland, G., Ott, A. et al. De prevalentie van parkinsonisme en de ziekte van Parkinson bij ouderen; het ERGO-onderzoek. Ned Tijdschr Geneeskd 1996 27 januari; 140(4) - Rohrer, J., Paviour, D., Vandrovcova, J., Hodges, J. et al. Novel L284R MAPT Mutation in a Family with an Autosomal Dominant Progressive Supranuclear Palsy Syndrome. Neurodegenerative Dis 2011;8:149–152. - Roncevic D, Palma J, Martinez J, Goulding N, Norcliffe-Kaufmann L, Kaufmann H. Cerebellar and parkinsonian phenotypes in multiple system atrophy: similarities, differences and survival. J Neural Transm. 2014;121:507–512. - Sato Y, Iwamoto J, Honda Y, Amano N. Vitamin D reduces falls and hip fractures in vascular parkinsonism but not in Parkinson’s disease. Ther Clin Risk Manag 2013;9:171–176. - Stamelou, M., Alonso – Canovas, A., Bhatia, K. Dystonia in Corticobasal Degeneration: A Review of the Literature on 404 Pathologically Proven Cases. Movement Disorders, Vol. 27, No. 6, 2012. DOI: 10.1002/mds.24992 - Stamelou, M., Höglinger, G. Atypical parkinsonism: an update. Curr Opin Neurol 2013, 26:401– 405DOI:10.1097/WCO.0b013e3283632da6 - Stamelou, M., Höghlinger, G. A Review of Treatment Options for Progressive Supranuclear Palsy. CNS Drugs (2016) 30:629–636. DOI 10.1007/s40263-016-0347-2 - Stankovic I, Krismer F, Jesic A, Antonini A, Benke T, Brown R, et al. Cognitive impairment in multiple system atrophy: a position statement by the Neuropsychology Task Force of the MDS multiple system atrophy (MODIMSA) Study Group. Mov Disord 2014;29:857–867. - Sturm, E., Stefanova, N. Multiple System Atrophy: Genetic or Epigenetic? Exp Neurobiol. 2014 Dec;23(4):277-291. - Thanvi B, Lo N, Robinson T. Vascular parkinsonism – an important cause of parkinsonism in older people. Age Ageing 2005;34:114-119.